Showing results (611-620 of 691) with videos related to
Sort By:
Pageof 70
Microbial Drug Resistance (Larchmont, N.Y.)|January 26, 2000
Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatisT Imai, K Watanabe, Y Mikami, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 23, 2011
Ferromagnetism in CaMn(1-x)Ir(x)O(3)S Mizusaki, J Sato, T Taniguchi, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 11, 2011
Magnetic ground states of CaRu(1-x)Mn(x)O(3)(0.2 ≤ x ≤ 0.9): a magnetic Compton scattering studyS Mizusaki, T Taniguchi, N Okada, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1995
Clinical experiences in the thermoradiotherapy for advanced gastric cancerY Nagata, M Hiraoka, Y Nishimura, et al.The Journal of Infectious Diseases|August 19, 2000
Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringensA E Bryant, R Y Chen, Y Nagata, et al.The Journal of Infectious Diseases|August 19, 2000
Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangreneA E Bryant, R Y Chen, Y Nagata, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 1, 1994
Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancerS I Masunaga, M Hiraoka, K Akuta, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 1, 1994
Site-specific phase I, II trials of hyperthermia at Kyoto UniversityM Hiraoka, Y Nishimura, Y Nagata, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 8, 2003
p53-dependent hyperthermic enhancement of tumour growth inhibition by X-ray or carbon-ion beam irradiationA Takahashi, I Ota, T Tamamoto, et al.European Journal of Immunology|November 28, 2000
A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individualsT Okugawa, Y Ikuta, Y Takahashi, et al.Pageof 70